Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device

Massimo Chessa; Gianfranco Butera; Mario Carminati

Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device

Massimo Chessa, Gianfranco Butera, Mario Carminati

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.

Original language	English
Pages (from-to)	142-144
Number of pages	3
Journal	Journal of Invasive Cardiology
Volume	19
Issue number	3
Publication status	Published - Mar 2007

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device'. Together they form a unique fingerprint.

Cite this

@article{70d0e50dfd0846359ee2efe6e64807c2,

title = "Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept{\texttrademark} device",

abstract = "During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept{\texttrademark} PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.",

author = "Massimo Chessa and Gianfranco Butera and Mario Carminati",

year = "2007",

month = mar,

language = "English",

volume = "19",

pages = "142--144",

journal = "Journal of Invasive Cardiology",

issn = "1042-3931",

publisher = "HMP Communications",

number = "3",

}

TY - JOUR

T1 - Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device

AU - Chessa, Massimo

AU - Butera, Gianfranco

AU - Carminati, Mario

PY - 2007/3

Y1 - 2007/3

N2 - During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.

AB - During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.

UR - http://www.scopus.com/inward/record.url?scp=33847662423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847662423&partnerID=8YFLogxK

M3 - Article

C2 - 17341783

AN - SCOPUS:33847662423

VL - 19

SP - 142

EP - 144

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 3

ER -

Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device

Abstract

ASJC Scopus subject areas

Other files and links

Cite this